Lafora disease gene therapy: EPM2A but not EPM2B overexpression results in Lafora body formation

Esther O. Alao, Mehrnaz Sheibani, Jun Wu, Ummay Marriam, Doretha Evans, Sahba Kasiri, Mayank Verma, Silvia Nitschke, Felix Nitschke, Steven J. Gray, Sharmistha Mitra, Berge A. Minassian

Open source

DOI
10.1016/j.neurot.2026.e00866
Published
2026-03
Container
Neurotherapeutics
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neurot.2026.e00866,
  title = {Lafora disease gene therapy: EPM2A but not EPM2B overexpression results in Lafora body formation},
  author = {Esther O. Alao and Mehrnaz Sheibani and Jun Wu and Ummay Marriam and Doretha Evans and Sahba Kasiri and Mayank Verma and Silvia Nitschke and Felix Nitschke and Steven J. Gray and Sharmistha Mitra and Berge A. Minassian},
  year = {2026},
  journal = {Neurotherapeutics},
  doi = {10.1016/j.neurot.2026.e00866},
  url = {https://doi.org/10.1016/j.neurot.2026.e00866}
}

RIS

TY  - JOUR
TI  - Lafora disease gene therapy: EPM2A but not EPM2B overexpression results in Lafora body formation
AU  - Esther O. Alao
AU  - Mehrnaz Sheibani
AU  - Jun Wu
AU  - Ummay Marriam
AU  - Doretha Evans
AU  - Sahba Kasiri
AU  - Mayank Verma
AU  - Silvia Nitschke
AU  - Felix Nitschke
AU  - Steven J. Gray
AU  - Sharmistha Mitra
AU  - Berge A. Minassian
PY  - 2026
JO  - Neurotherapeutics
DO  - 10.1016/j.neurot.2026.e00866
UR  - https://doi.org/10.1016/j.neurot.2026.e00866
ER  - 

APA

Alao, E. O., Sheibani, M., Wu, J., Marriam, U., Evans, D., Kasiri, S., Verma, M., Nitschke, S., Nitschke, F., Gray, S. J., Mitra, S., & Minassian, B. A. (2026). Lafora disease gene therapy: EPM2A but not EPM2B overexpression results in Lafora body formation. Neurotherapeutics. https://doi.org/10.1016/j.neurot.2026.e00866

Source records